Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Accumulated Depreciation & Amortization (2016 - 2018)

Historic Accumulated Depreciation & Amortization for Soleno Therapeutics (SLNO) over the last 6 years, with Q4 2018 value amounting to $93000.0.

  • Soleno Therapeutics' Accumulated Depreciation & Amortization rose 2567.57% to $93000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $93000.0, marking a year-over-year increase of 2567.57%. This contributed to the annual value of $93000.0 for FY2018, which is 2567.57% up from last year.
  • According to the latest figures from Q4 2018, Soleno Therapeutics' Accumulated Depreciation & Amortization is $93000.0, which was up 2567.57% from $74000.0 recorded in Q4 2017.
  • In the past 5 years, Soleno Therapeutics' Accumulated Depreciation & Amortization registered a high of $211850.0 during Q4 2015, and its lowest value of $50429.0 during Q4 2016.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $114162.0 (2014), whereas its average is $120919.2.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 7619.59% in 2016, then surged by 4674.1% in 2017.
  • Quarter analysis of 5 years shows Soleno Therapeutics' Accumulated Depreciation & Amortization stood at $160912.0 in 2014, then soared by 31.66% to $211850.0 in 2015, then tumbled by 76.2% to $50429.0 in 2016, then soared by 46.74% to $74000.0 in 2017, then grew by 25.68% to $93000.0 in 2018.
  • Its Accumulated Depreciation & Amortization was $93000.0 in Q4 2018, compared to $74000.0 in Q4 2017 and $50429.0 in Q4 2016.